Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Athena Technology Acquisition (ATEK) Competitors

Athena Technology Acquisition logo

ATEK vs. CRTX, OMCL, MDRX, HSTM, NETD, RRAC, IPXX, CDRO, VACH, and SIMA

Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), Veradigm (MDRX), HealthStream (HSTM), Nabors Energy Transition Corp. II (NETD), Rigel Resource Acquisition (RRAC), Inflection Point Acquisition Corp. II (IPXX), Codere Online Luxembourg (CDRO), Voyager Acquisition (VACH), and SIM Acquisition Corp. I (SIMA).

Athena Technology Acquisition vs.

Athena Technology Acquisition (NYSE:ATEK) and Cortexyme (NASDAQ:CRTX) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their dividends, community ranking, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Athena Technology Acquisition Neutral
Cortexyme Neutral

Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.

Company Net Margins Return on Equity Return on Assets
Athena Technology AcquisitionN/A N/A N/A
Cortexyme N/A -70.96%-63.53%

17.3% of Athena Technology Acquisition shares are held by institutional investors. Comparatively, 63.2% of Cortexyme shares are held by institutional investors. 81.7% of Athena Technology Acquisition shares are held by company insiders. Comparatively, 27.9% of Cortexyme shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Athena Technology Acquisition received 478 more outperform votes than Cortexyme when rated by MarketBeat users. However, 64.44% of users gave Cortexyme an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote.

CompanyUnderperformOutperform
Athena Technology AcquisitionOutperform Votes
632
63.65%
Underperform Votes
361
36.35%
CortexymeOutperform Votes
154
64.44%
Underperform Votes
85
35.56%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Athena Technology AcquisitionN/AN/AN/AN/AN/A
CortexymeN/AN/A-$89.94M-$2.97-0.70

Summary

Athena Technology Acquisition beats Cortexyme on 5 of the 7 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEK vs. The Competition

MetricAthena Technology AcquisitionHolding Offices IndustryUnclassified SectorNYSE Exchange
Market Cap$129.10M$425.40M$109.13M$20.11B
Dividend YieldN/A7.57%5.20%3.49%
P/E RatioN/A2.181.0642.54
Price / SalesN/A138.621.2518.41
Price / CashN/A80.91100.1721.28
Price / BookN/A73.35519.864.65
Net IncomeN/A$32.40M$2.46M$985.54M

Athena Technology Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEK
Athena Technology Acquisition
N/A$11.61
-1.4%
N/A+7.6%$129.10MN/A0.002,021
CRTX
Cortexyme
N/A$2.08
+13.0%
N/A+101.1%$62.71MN/A-0.7055
OMCL
Omnicell
3.1333 of 5 stars
$44.11
+5.5%
$52.00
+17.9%
+26.7%$2.04B$1.15B-109.693,650Analyst Forecast
Analyst Revision
News Coverage
High Trading Volume
MDRX
Veradigm
0.5515 of 5 stars
$10.99
+4.6%
$11.75
+6.9%
-15.9%$1.18B$1.50B0.008,000Gap Up
HSTM
HealthStream
4.044 of 5 stars
$31.82
+1.7%
$31.50
-1.0%
+22.8%$967.96M$279.06M48.951,092
NETD
Nabors Energy Transition Corp. II
N/A$10.73
+0.1%
N/A+4.6%$409.03MN/A0.00N/A
RRAC
Rigel Resource Acquisition
N/A$11.50
flat
N/AN/A$368.81MN/A0.002,021
IPXX
Inflection Point Acquisition Corp. II
N/A$10.78
+0.6%
N/A+4.4%$336.87MN/A0.00N/A
CDRO
Codere Online Luxembourg
3.1336 of 5 stars
$7.30
flat
$9.50
+30.1%
+136.2%$330.69MN/A0.00230Short Interest ↓
News Coverage
VACH
Voyager Acquisition
N/A$10.02
flat
N/AN/A$316.83MN/A0.00N/A
SIMA
SIM Acquisition Corp. I
N/A$10.00
+0.1%
N/AN/A$306.70MN/A0.00N/A

Related Companies and Tools


This page (NYSE:ATEK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners